CrossRefPubMed 41. Monack DM, Raupach B, Hromockyj AE, Falkow S:Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc Natl Acad Sci USA 1996, 93:9833–9838.CrossRefPubMed

42. Mills SD, Boland A, Sory MP, Smissen P, Kerbourch C, Finlay BB, Cornelis GR:Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc Natl Acad Sci USA 1997, 94:12638–12643.CrossRefPubMed 43. Albee L, Shi B, Perlman H: Aspartic protease and caspase 3/7 activation are central for macrophage apoptosis following infection with Escherichia coli. J Leukoc Biol 2007, 81:229–237.CrossRefPubMed 44. Merien

F, Baranton G, Perolat P: Invasion of Vero cells and induction learn more of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence. Infect Immun 1997, 65:729–738.PubMed 45. Liu YY, Zheng W, Li LW, Mao Y, Yan J: Pathogenesis of leptospirosis: interaction of Leptospira interrogans with in vitro cultured mammalian cells. Med Microbiolo Immunol 2007, 196:233–239.CrossRef 46. Jin DD, Ojcius DM, Sun D, Dong HY, Luo YH, Mao YF, Yan J:Leptospira interrogans induces apoptosis in macrophages via caspase-8- AZD2281 clinical trial and caspase-3-dependent pathways. Infect Immun 2009, 77:799–809.CrossRefPubMed 47. Hueck CJ: Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Bio Rev 1998, 62:379–433. 48. Stuber K, Frey J, Burnens AP, Kuhnert P: Detection of type III secretion genes as a general indicator of bacterial virulence. CYTH4 Mole Cell Probes 2003, 17:25–32.CrossRef 49. Kubori T, Matsushima Y, Nakamura D, Uralil J, Lara-Tejero M, Sukhan A, Galán JE, Aizawa SI: Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 1998, 280:602–605.CrossRefPubMed 50. Young GM, Schmiel DH, Miller VL:

A new pathway for the secretion of virulence factors by bacteria: the flagellar export apparatus functions as a protein-secretion system. Proc Natl Acad Sci USA 1999, 96:6456–6461.CrossRefPubMed 51. Arora SK, Ritchings BW, Almira EC, Lory S, Ramphal R: Cloning and characterization of Pseudomonas aeruginosa fliF, necessary for flagellar assembly and bacterial adherence to mucin. Infect Immun 1996, 64:2130–2136.PubMed 52. Mecsas JJ, Strauss EJ: Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands. Emerg Infect Dis 1996,2(4):270–288.CrossRefPubMed 53. Warren SM, Young GM: An amino-terminal secretion signal is required for YplA export by the Ysa, Ysc, and flagellar type III secretion systems of Yersinia enterocolitica biovar 1B. J Bacteriol 2005, 187:1430–40.CrossRef 54. Viriyakosol S, Matthias MA, Swancutt MA, Kirkland TN, Vinetz JM: Toll-like receptor 4 protects against lethal Leptospira interrogans serovar Icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden.

We propose that K+ complies with all the above-listed requirements, which is unique in contrast to other mono- and divalent metallic ions (Fig. 3). Further peptide evolution at later stages could have occurred due to the presence of other abundant cations, e.g., Na+, Mg2+ and Ca2+, which may have resulted from their lower diffusion and higher hydration energy. The elongation and functionalization of the peptides might also have been driven by other inorganic cations or clays or minerals (Ferris et al. 1996; Hill and Orgel 1999; Rode et al. 1999; Rees and

Howard 2003) because they form more stable complexes with biomolecules. We assume that our findings could be useful not only for discussions of the origin of life but also for more sophisticated research on the role of the physical-chemical properties of inorganic ions, biomolecules and nanoparticles

in molecular physiology. The EX 527 order data on the difference in K+ versus Na+ coordination- and diffusion-controlled condensation of amino acids may be of particular interest in understanding ion-exchange regulation by the membrane Na+/K+-ATPase pump. Acknowledgments We are grateful to Prof. Yuri V. Trushin and Prof. Vladimir G. Dubrovskii for helpful discussions of the physics of diffusion, Dr. Viktor G. Zgoda for his discussions of mass spectrometry and PhD student Ivan N. Terterov for his technical assistance. This work was performed PD0325901 solubility dmso under a grant from the Presidium of the Russian Academy of Sciences. Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. References Aronson PS, Boron WF, Boulpaep EL (2009) Transport of solutes and water. In: Boron WF, Boulpaep EL (eds) Medical physiology, 2nd edn.

Saunders Elsevier, Philadelphia, pp 106–146CrossRef Brack Interleukin-3 receptor A (1987) Selective emergence and survival of early polypeptides in water. Orig Life Evol Biosph 17:367–379PubMedCrossRef Dubrovskii VG, Nazarenko MV (2010) Nucleation theory beyond the deterministic limit. I. The nucleation stage. J Chem Phys 132:114507PubMedCrossRef Eschenmoser A (2003) The search for the chemistry of life’s origin. Tetrahedron 63:12821–12844CrossRef Ferris LP, Hill AR Jr, Liu R, Orgel LE (1996) Synthesis of long prebiotic oligomers on mineral surfaces. Nature 381:59–61PubMedCrossRef Fox SW (1960) How did life begin? Science 132:200–208PubMedCrossRef Freedman J (1995) In: Sperelakys N (ed) Cell physiology, source book. Biophysical chemistry of cellular electrolytes. Academic, San Diego, pp 3–17 Galimov EM, Ryzhenko BN, Cherkasova EV (2011) Estimation of the composition of the Earth’s primary aqueous phase. 2. Synthesis from the mantle and igneous rock material. Comparison with synthesis from the carbonaceous chondrite material.

9%), and IT2 and IT4 (13/34, 38.2%) respectively. In addition, one IT3 strain 0063 and one IT5 strain L43 present in two individual branches formed subgroups

C and D respectively (Table 2). Phylogeny and population history of L. innocua As aforementioned, L. innocua was genetically monophyletic (π = 1.06%) as compared Caspases apoptosis to L. monocytogenes (π = 4.38%). When sequence data were analyzed after stratification by subgroups, the number of polymorphisms and genetic diversity within each subpopulations were reduced (Table 3), suggesting a barrier for genetic exchange between these L. innocua subgroups. Such barrier was also observed between L. monocytogenes lineages (Table 3), consistent with one previous report [21]. Tajima’s D test revealed that L. innocua and L. monocytogenes did not evolve under neutrality. A marginal positive value of Tajima’s D observed for ribC in L. monocytogenes (1.9963, 0.05 < p < 0.10) became smaller or negative when analyses were performed for separate lineages, suggesting a divided population structure. Similarly, significant or marginal positive Tajima's D values were observed for gyrB (2.0401, p < 0.05) in L. monocytogenes lineage II, and for sigB (2.0426, p < 0.05) and gap (1.7746, 0.05 this website < p < 0.10) in lineage III, supporting that lineages II and III represented diverse populations as compared to lineage I (Table 4). On the other hand, gyrB (-2.2650, p < 0.01), betL (-2.5954,

p < 0.001) and gap (-2.4190, p < 0.01) showed significant negative Tajima's D values in L. innocua, indicative Thymidylate synthase of a bottleneck or selective sweep [22, 23]. Also, Tajima’s D were marginal negative for betL in L. innocua subgroup A (-1.7315, 0.05 < p < 0.10) and gap in subgroup B (-1.6523, 0.05 < p < 0.10) (Table 4). Table 4 Tajima's D test for the L. innocua-L. monocytogenes clade Gene L. innocua L. monocytogenes   A B all I II III all gyrB

-0.3479 0.3871 -2.2650** -1.6671# 2.0401* 0.0136 0.7361 dapE 0.7970 1.1138 -1.0723 -0.0394 -0.4958 0.9003 -0.3265 hisJ 1.2046 0.1750 0.2478 -0.1104 -0.6528 0.0336 1.4256 sigB -0.1097 0.5901 0.2092 0.5444 -1.1117 2.0426* 1.2456 ribC 0.0511 0.2773 0.2987 1.5368 -1.5344 0.4909 1.9963# purM 0.5044 0.2217 -1.4464 0.0235 -0.2856 0.9867 0.4698 betL -1.7315# -1.5047 -2.5954*** -0.2912 -0.1839 0.5179 0.0554 gap -1.1648 -1.6523# -2.4190** -0.6910 -0.8223 1.7746# 0.2481 tuf N/Aa 0.9505 -0.0101 N/A 0.8198 0.5380 0.4709 Concatenated 0.1719 0.1492 0.3847 0.3655 -0.7070 0. 7379 0.7452 #, 0.05 < p < 0.10; *, p < 0.05; **, p < 0.01; ***, p < 0.001. a. No polymorphisms in the data, resulting in inability to compute Tajima’s test. The exterior/interior branch length ratio test demonstrated that L. innocua and its subgroup A as well as L. monocytogenes and its lineage I showed a significantly smaller exterior/interior branch length ratio (p < 0.05) than expected under the coalescent model (Figure 2).

Allergol Int 2010, 59:161–166.PubMedCrossRef Competing interests The authors declare no competing interests concerning this work. Authors’ contributions SKu and SKa conceived and designed the experiments. SKu and TO performed animal experiments. SKu and HY performed real time PCR procedures. SKu, SKa and HT analyzed the data. TO, HY and KA contributed reagents/materials/analysis tools. All authors

read and approved the final manuscript.”
“Erratum to: Int J Clin Oncol (2010) DOI 10.1007/s10147-010-0111-4 During the editorial production process, an error was inadvertently created LY2606368 order in the title of this article. The correct version is “Successful long-term remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic non-seminomatous germ cell tumor: an additional report to Int J Clin Oncol 2007; 12:485–487”. The publisher sincerely apologizes for the error.”
“Background The ubiquitous saprophytic mould Aspergillus fumigatus is known to cause a spectrum of diseases in humans, including allergic syndromes, noninvasive infections, and invasive aspergillosis, a condition associated with significant morbidity and mortality [1]. A. fumigatus is one of the human pathogenic fungi that have a natural habitat in the environment, including soil and plants

[2]. Some members of the azole drug class, which includes voriconazole (VRC) and posaconazole (POS), have been shown to be effective in the treatment of invasive aspergillosis [3], and for a long time, azole resistance among clinical A. fumigatus isolates was considered to be an uncommon Cyclin-dependent kinase 3 finding. Seliciclib However, multiazole resistance is emerging and is increasingly recognized as a

cause of treatment failure [4, 5]. In agriculture, thousands of tons of azoles are sold annually for the purpose of plant protection, either to prevent or to control fungal growth that can cause extensive loss of crops or to ease the problem of postharvest spoilage of plants and fruits [6]. The mechanism of action of all azoles – irrespectively of their chemical structure and variable biological properties – is based on its interference with the activity of fungal lanosterol 14 alpha-demethylase, an enzyme encoded by Cyp51A gene in A. fumigatus that is responsible for the transformation of lanosterol in ergosterol, an essential component of the fungal cytoplasmatic membrane. The inhibition of ergosterol formation results in cell membrane disorganization and impairment of fungal growth. Therefore, azoles are considered fungistatic rather than fungicidal, and it is well known that a strong and persistent antimicrobial pressure can lead to the selection of resistant clones, particularly if the drug effect is static rather than microbicidal [7]. Since azoles are the mainstay treatment for both human and agricultural fungal diseases, a major concern is the predictable emergence of cross-resistance to clinical A.

albicans strains and a S. aureus strain using AFM. Figure 1 Schematic illustration of the principle of atomic force microscopy and definition of different hyphal regions. (A) Schematic presentation of AFM set-up. A sample with attached C. albicans cells is positioned

by a xyz piezo scanner, while a bacterium attached to a tipless AFM cantilever is brought into contact with the hyphal surface. The deflection of the cantilever upon retract is a measure NVP-LDE225 of the adhesion forces between a bacterium and the hyphal surface and is detected by an optical laser. The laser beam is focused on the very end of the cantilever and reflected onto a position sensitive detector from which the adhesion forces can be calculated, provided the mechanical properties of the cantilever are known. (B) Schematic indication of the different hyphal regions defined for bacterial-hyphal adhesion force measurements. Methods Strains, growth conditions and harvesting C. albicans SC5314 (a commonly used, wild type reference strain), C. albicans MB1 (a biofilm-associated, clinical isolate [27]) and bacterial strain S. aureus MLN0128 cell line NCTC8325-4 (wild type) were used. To generate green fluorescent protein (GFP)-expressing S. aureus NCTC8325-4, pMV158GFP [28] was introduced into competent bacterial cells by electroporation [29]. Selection of subsequent transformants was performed on tryptone soya broth with 1.5% bactoagar (TSB, Oxoid,

Basingstoke, UK) plates containing 10 μg/mL tetracycline. S. aureus NCTC8325-4 click here that received pMV158GFP (S. aureus NCTC8325-4GFP) showed constitutive GFP expression that could be visualized using fluorescence microscopy. Strains were grown on TSB agar plates, supplemented with tetracycline when appropriate. Single colonies were inoculated in 5 mL TSB containing 10 μg/mL tetracycline for bacterial pre-cultures or 5 mL yeast nitrogen

base acids (YNB; Difco, Sparks, USA) pH 7, containing 0.5% D-glucose for C. albicans pre-cultures. S. aureus was routinely grown at 37°C while C. albicans was grown at 30°C to prevent hyphal formation for 24 h with rotation (150 rpm) and used to inoculate a main culture (1:50 dilution of pre-culture). Main bacterial cultures were grown for an additional 18 h under the same conditions. C. albicans hyphae were induced by growing a culture (1:50 dilution) for 4 h with rotation (150 rpm) at 37°C in 12 wells tissue culture polystyrene plates (Costar, Corning Inc., NY, USA). Hyphal formation was obtained at 90-95% efficiency under these conditions, as confirmed by phase contrast microscopy. Main cultures were harvested by centrifugation for 5 min at 6,250 x g and 14,800 x g for S. aureus and C. albicans, respectively, followed by two washes with phosphate buffered saline (PBS: 10 mM potassium phosphate, 0.15 M sodium chloride, pH 7) and resuspended in PBS. Adhesion of staphylococci to hyphae and yeast using fluorescence microscopy Adhesion of S. aureus NCTC8325-4GFP to C.

Tumori 2000, 86: 465–469.PubMed 24. Grothey A: Oxaliplatin-safety profile: Neurotoxicity. Oncol 2003, 30: 5–13. 25. Tournigrand C, Cervantes A, Figer A, Lledo G, Flesch M, Buyse M, Mineuer L, Calola E, Etienne PL, Rivera F, Chirivella I, Perez-Staub N, Louvet C, André T, Taban-Fisch I, de Gramont A: OPTIMOX 1: a randomized study of FOLFOX4 or FOLFOX7 with Oxaliplatin in a stop-and-go fashion in advanced colorectal cancer-a GERCOR study. J Clin Oncol 2006, 24: 394–400.CrossRef 26. Figer A, Perez-Staub Neratinib N, Carola E, Tournigrand C, Lledo G, Flesch

M, Barcelo R, Cervantes A, André T, Colin P, Louvet C, de Gramont A: FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX 1 study. Cancer 2007, 110: 2666–2671.CrossRefPubMed Competing Vemurafenib order interests The authors declare that they have no competing interests. Authors’ contributions AK, KK, HY, and MI conceived and designed the study, SS, AK, KK, HY, and HT collected and assembled the data, SS performed the statistical analysis, and SS wrote the manuscript. All authors have read and approved the final manuscript.”
“Background In the homeobox gene family, the caudal-related CDX2 gene encodes

for an intestine-specific transcription factor involved in both cell turnover and intestinal differentiation [1]. Nuclear immunostain for Cdx2 is restricted to the native intestinal epithelia and its de novo expression is considered as suitable marker of a newly achieved intestinal commitment [2, 3]. Barrett’s esophagus (BE) is defined as replacement of the native esophageal squamous epithelium by columnar (intestinalized) mucosa [4–6]. Longstanding exposure of the squamous esophageal epithelium

learn more to gastric reflux is a primary risk factor for columnar metaplasia, which is consistently considered as precursor of esophageal adenocarcinoma (Ac) [7, 8]. Esophageal Ac is the final step in a sequence of phenotypic changes that include long-standing esophagitis, columnar cell metaplasia, and non-invasive neoplasia (NiN). The molecular derangements occurring in each of these phenotypic changes are largely unknown and they involve both genetic and chromosomal instability [9, 10]. More information on such molecular changes is crucial in any strategy of primary prevention of Barrett’s Ac [11–14]. In humans, both practical and ethical limitations prevent any sequential exploration of the cascade of Barrett’s Ac, so experimental models are used to characterize the biological alterations leading to neoplastic transformation [15–31]. In this experimental study, the expression of Cdx2 protein was tested over the whole spectrum of phenotypic lesions detected in a surgical murine model of esophago-gastroduodenal anastomosis (EGDA) resulting in longstanding esophageal reflux of gastro-duodenal contents [19, 21–24, 29].

Antimicrob Agents Chemother 1994,38(10):2380–2386.PubMedCentralPubMedCrossRef 37. Ohno H, Koga H, Kohno S, Tashiro T, Hara K: Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother 1996,40(4):1053–1056.PubMedCentralPubMed

38. Mani C, Selvakumar N, Narayanan S, Narayanan PR: Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol 2001,39(8):2987–2990.PubMedCentralPubMedCrossRef 39. Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC: Drug Resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol 2009, 8:97–112. 40. Mokrousov AZD1152-HQPA price I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B: High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother 2002,46(5):1417–1424.PubMedCentralPubMedCrossRef 41. Sajduda A, Brzostek A, Poplawska M, Augustynowicz-Kopec E, Zwolska Z, Niemann S, Dziadek J, Hillemann D: Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated

in Poland. J Clin Microbiol 2004,42(6):2425–2431.PubMedCentralPubMedCrossRef 42. van Doorn HR, An DD, de Jong MD, Lan NT, Hoa DV, Quy HT, Chau NV, Duy Adriamycin datasheet PM, Tho DQ, Chinh NT, Farrar JJ, Caws M: Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR. Int J Tuberc Lung Dis 2008,12(7):736–742.PubMed 43. Bakonyte D, Baranauskaite A, Cicenaite J, Sosnovskaja A, Stakenas P: Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob Agents Chemother 2003,47(6):2009–2011.PubMedCentralPubMedCrossRef 44. buy Temsirolimus Tudo G, Gonzalez J,

Obama R, Rodriguez JM, Franco JR, Espasa M, Simarro PR, Escaramis G, Ascaso C, Garcia A, Jimenez De Anta MT: Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Int J Tuberc Lung Dis 2004,8(1):15–22.PubMed 45. Chaoui I, Sabouni R, Kourout M, Jordaan AM, Lahlou O, Elouad R, Akrim M, Victor TC, El Mzibri M: Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. J Infect Dev Ctries 2009,3(4):278–284.PubMed 46. Cho EH, Bae HK, Kang SK, Lee EH: Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea. Korean J Lab Med 2009,29(5):455–460.PubMedCrossRef 47.

This discrepancy may be due to different subtypes of breast cancers and different percentages of samples from primary and metastatic breast tumors. Although CD44+/CD24- percentage was not associated with ER or HER2 expression, we observed an association between high CD44+/CD24- percentage and PR expression. This linkage was more prominent in samples from

recurrent and metastatic tumors with more than 25% CD44+/CD24- cells. In contrast, previous studies showed that the presence of CD44+/CD24- tumor cells was not associated with ER or PR status [20]. CD44+/CD24- cells have been observed in 63% of basal-like subtype (SR-HER2- basal-like) breast tumors.[20] Although we did not observe a significant difference in the proportion of CD44+/CD24- selleckchem cells in samples from tumors with and without basal-like features, we found that the CD44+/CD24- subpopulation was higher in samples of recurrent and metastatic tumors with basal-like features. Several studies have shown an association between CD44+/CD24-

cells and the metastasis of basal-like breast cancers. For example, the expression of several metastasis-associated genes was found to be higher in cells with than without the CD44+/CD24- phenotype, and only malignant cell lines with the CD44+/CD24- subpopulation were able to invade matrigel, indicating that CD44+/CD24- cancer cells are more metastatic than non-CD44+/CD24- cells [21, 22]. Importantly, a unique 186-gene invasiveness gene signature has been observed in CD44+/CD24- Obeticholic Acid cell line malignant cells,[22] linking the presence

of CD44+/CD24- cells to distant metastasis although not to survival.[8, 23] We found that the time to tumor relapse (including recurrence and metastasis) was significantly shorter in patients with than without CD44+/CD24- tumor cells. Metastasis is a complex process involving invasion, intravasation, survival in the blood stream, extravasation and homing and proliferation at the sites of metastasis.[8, 24, 25] The poor prognosis of patients with Methane monooxygenase primary tumors having higher levels of CD44+/CD24- cells, but whose metastatic cells had the CD44±/CD24+ phenotype,[26, 27] suggests that CD44+/CD24- tumor cells may be a transient phenotype and that these cells have an intrinsic program to transition to a phenotype that enhances their heterotypic interaction and survival/proliferation in distant organs.[8] This hypothesis, however, cannot explain the difference in time to tumor relapse in patients with and without CD44+/CD24- cancer cells who had undergone surgical resection plus immunotherapy. Conclusion We observed variations in the prevalence of CD44+/CD24- tumor cells in breast tumors of different subtypes. This phenotype was highly prevalent in primary tumors with high PR expression and in secondary tumors.

Acknowledgements We thank Rupert Mutzel for continuous

generous support and Jan Faix and Markus Maniak for providing antibodies. This work was funded by “”Fördermittel der Freie Universität Berlin”" (BW), the Deutsche Forschungsgemeinschaft (RI 1034/4), and the Köln Fortune Program of the Medical Faculty, University of Cologne (FR). References 1. DeLeo FR, Hinnebusch BJ: A plague upon the phagocytes. Nat Med 2005, 11:927–928.CrossRefPubMed 2. Cornelis GR: How Yops find their way out of Yersinia. Mol Microbiol 2003, 50:1091–1094.CrossRefPubMed SAHA HDAC mouse 3. Aepfelbacher M, Trasak C, Ruckdeschel K: Effector functions of pathogenic Yersinia species. Thromb Haemost 2007, 98:521–529.PubMed 4. Deleuil F, Mogemark L, Francis MS, Wolf-Watz H, Fallman M: Interaction between the Yersinia protein tyrosine phosphatase YopH and eukaryotic Cas/Fyb is an important virulence mechanism. Cell Microbiol 2003, 5:53–64.CrossRefPubMed 5. Bruckner S, Rhamouni S, Tautz L, Denault JB, Alonso A, Becattini B,

Salvesen GS, Mustelin T:Yersinia phosphatase induces mitochondrially dependent apoptosis of T cells. J Biol Chem 2005, 280:10388–10394.CrossRefPubMed 6. Zhang Y, Ting AT, Marcu KB, Bliska JB: Inhibition of MAPK and NF-κB pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J Immunol 2005, 174:7939–7949.PubMed 7. BTK inhibitor Zhou H, Monack DM, Kayagaki N, Wertz I, Yin J, Wolf B, Dixit VM:Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation. J Exp Med 2005, 202:1327–1332.CrossRefPubMed 8. Benabdillah R, Mota LJ, Lutzelschwab S, Demoinet E, Cornelis GR: Identification of a nuclear targeting signal in YopM from Yersinia spp. Microb

Pathog 2004, 36:247–261.CrossRefPubMed 9. Adkins I, Koberle M, Grobner S, Bohn E, Autenrieth IB, Borgmann S:Yersinia outer proteins E, H, P, and T differentially target the cytoskeleton and inhibit phagocytic capacity of dendritic cells. Int J Med Microbiol 2007, 297:235–244.CrossRefPubMed 10. Von Pawel-Rammingen U, Telepnev MV, Schmidt G, Aktories K, Wolf-Watz H, Rosqvist Branched chain aminotransferase R: GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol Microbiol 2000, 36:737–748.CrossRef 11. Andor A, Trulzsch K, Essler M, Roggenkamp A, Wiedemann A, Heesemann J, Aepfelbacher M: YopE of Yersinia , a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endothelial cells. Cell Microbiol 2001, 3:301–310.CrossRefPubMed 12. Black DS, Bliska JB: The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol Microbiol 2000, 37:515–27.CrossRefPubMed 13. Grosdent N, Maridonneau-Parini I, Sory M, Cornelis G: Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect Immun 2002, 70:4165–4176.

13 and the aac (6′)-Ih plasmid gene of Acinetobacter baumannii. Antimicrob Agents Chemother 1994, 38:1883–1889.PubMedCentralPubMedCrossRef 52. Shaw K, Cramer C, Rizzo M, Mierzwa R, Gewain K, Miller G, Hare R: Isolation, characterization, and DNA sequence analysis of an AAC (6′)-II gene from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1989, 33:2052–2062.PubMedCentralPubMedCrossRef 53. Park CH, Robicsek

A, Jacoby GA, Sahm D, Hooper DC: Prevalence in the United States of aac (6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006, 50:3953–3955.PubMedCentralPubMedCrossRef 54. Dijkshoorn L, Nemec A, Seifert H: An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5:939–951.PubMedCrossRef 55. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA: MAPK Inhibitor Library Global challenge of multidrug-resistant Acinetobacter

baumannii. Antimicrob Sirolimus clinical trial Agents Chemother 2007, 51:3471–3484.PubMedCentralPubMedCrossRef 56. Vakulenko SB, Donabedian SM, Voskresenskiy AM, Zervos MJ, Lerner SA, Chow JW: Multiplex PCR for detection of aminoglycoside resistance genes in enterococci. Antimicrob Agents Chemother 2003, 47:1423–1426.PubMedCentralPubMedCrossRef 57. Vanhoof R, Godard C, Content J, Nyssen H, Hannecart-Pokorni E: Detection by polymerase chain reaction of genes encoding aminoglycoside-modifying enzymes in methicillin-resistant Staphylococcus aureus isolates of epidemic phage types. J Med Microbiol 1994, 41:282–290.PubMedCrossRef 58. Han D, Unno T, Jang J, Lim K, Lee S-N, Ko G, Sadowsky MJ, Hur H-G: The occurrence of virulence traits among high-level aminoglycosides resistant Enterococcus isolates obtained from feces of humans, animals, and birds in South Korea. Int J Food Microbiol 2011, 144:387–392.PubMedCrossRef 59. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, Cook P, Wormser GP: Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994, 38:1363–1367.PubMedCentralPubMedCrossRef

60. Cepharanthine Leclercq R: Enterococci acquire new kinds of resistance. Clin Infect Dis 1997, 24:S80-S84.PubMedCrossRef 61. McKay G, Thompson P, Wright G: Broad spectrum aminoglycoside phosphotransferase type III from Enterococcus: overexpression, purification, and substrate specificity. Biochemistry 1994, 33:6936–6944.PubMedCrossRef 62. Shaw K, Rather P, Hare R, Miller G: Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 1993, 57:138–163.PubMedCentralPubMed 63. Fouhy F, Guinane CM, Hussey S, Wall R, Ryan CA, Dempsey EM, Murphy B, Ross RP, Fitzgerald GF, Stanton C: High-throughput sequencing reveals the incomplete, short-term, recovery of the infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamycin.